|
|
|
|
|
by gramakri
3222 days ago
|
|
Thanks for the touching story and it's great to see medical startups like this. Can you clarify how you reached the 90% number given that the detection is 15 years before the disease and your startup is only 3 years old. How were these numbers measured? If I may throw in another question, what is the biggest challenge your company faces? It looks like there is no reason not to choose your product. |
|
Regarding your second question/comment, we have just launched, and you are absolutely right, there is no reason not to choose our product. The biggest challenge is the huge skepticism in the medical community towards any novel technology related to Alzheimer's disease, given all prior failed big claims by others.